Report Description

India sulbactam market is expected to grow at a steady rate during the forecast period. The bacterial cells produce β-lactamase which reduces the antibiotic activity and helps the bacteria to develop resistance against that particular antibiotic. Sulbactam here serves as a β-lactamase inhibitor which binds to the enzyme and does not allow it to degrade the antibiotic. This in turn has increased the demand for sulbactam, which is being used in combination with broad spectrum antibiotics like ampicillin. This in turn is expected to positively influence the market growth through FY2026. Additionally, supportive government policies and schemes such as production linked incentive scheme for indigenous manufacturing of APIs, establishment of bulk drug parks, among others launched by the government of India are expected to create lucrative opportunities for the market growth over the next few years.

The India Sulbactam market is segmented based on composition, source, form, distribution channel, application, end user, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period. This can be attributed to the increased outsourcing activities by the major companies in order to focus on their R&D activity and expansion plans. Additionally, contract manufacturing organizations offer greater customer satisfaction, competitive pricing and can provide bulk orders in lesser duration.

The major players operating in the India sulbactam market are Fresenius Kabi India Pvt. Ltd., M N Pharmaceuticals Pvt. Ltd., Morepen Laboratories Ltd.,      Unichem Laboratories Ltd., Hospira Healthcare India Pvt. Ltd., AdvaCare Pharma LLP,       Innovexia Lifesciences Private Limited, Osper Pharmaceuticals Pvt. Ltd., Torrent Laboratories Pvt. Ltd., Glenmark Pharmaceuticals Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India sulbactam market from FY2016 to FY2019.
  • To estimate and forecast the market size of India sulbactam market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India sulbactam market based on composition, source, form, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India sulbactam market.
  • To identify drivers and challenges for India sulbactam market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India sulbactam market.
  • To identify and analyze the profile of leading players operating in India sulbactam market.
  • To identify key sustainable strategies adopted by market players in India sulbactam market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India sulbactam market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Sulbactam manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to sulbactam

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India sulbactam market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Sulbactam Market, By Composition:
    • Single
    • Combinational
  • India Sulbactam Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Sulbactam Market, By Form:
    • Intramuscular Injection
    • Intravenous Injection
    • Powder Solution
    • Others
  • India Sulbactam Market, By Distribution Channel:
    • Online
    • Offline
  • India Sulbactam Market, By Application:
    • Respiratory Infections
    • Skin Infections
    • Urinary Infections
    • Others
  • India Sulbactam Market, By End User:
    • Adult
    • Pediatric
  • India Sulbactam Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India sulbactam market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Sulbactam market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Sulbactam Market

4.    Executive Summary

5.    Manufacturing Sulbactam

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Sulbactam

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Sulbactam Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Composition (Single, Combinational)

7.2.2.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.3.     By Form (Intramuscular injection, Intravenous injection, Powder Solution, Others)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Application (Respiratory Infections, Skin Infections, Urinary Infections, Others)

7.2.6.     By End User (Adult v/s Pediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Fresenius Kabi India Pvt. Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  M N Pharmaceuticals Pvt. Ltd.

14.1.3.  Morepen Laboratories Ltd.

14.1.4.  Unichem Laboratories Ltd.

14.1.5.  Hospira Healthcare India Pvt. Ltd.

14.1.6.  AdvaCare Pharma LLP

14.1.7.  Innovexia Lifesciences Private Limited

14.1.8.  Osper Pharmaceuticals Pvt. Ltd.

14.1.9.  Torrent Laboratories Pvt. Ltd.

14.1.10.                Glenmark Pharmaceuticals Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer 

Figures and Tables

Frequently asked questions